Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
Salihu Asimawu, Medical Laboratory Science Student and Research and Innovation Enthusiast at Ahmadu Bello University, shared a post on LinkedIn:
”Inflammation Is Not a Disease
Today in immunology class, we discussed immune reactions in tissue damage. The lecturer reminded us that inflammation is not a disease – it’s a natural physiological process that helps restore the body’s homeostasis.
He gave a vivid example: ‘Imagine someone barges into your house with a knife, trying to take over. You, as the owner, must resist and fight – not just run away. That’s exactly what inflammation does.’
I murmured to myself: if it were me, I’d run away – I definitely don’t have the strength to face the person, let alone the knife.
But then I realized: our immune system doesn’t run away. It stands its ground and fights tirelessly until the threat is neutralized. Every day, our body protects us, often without us even noticing.
Unlike me (and probably some of us), who would hide, our immune system shows true courage every day. Maybe it’s time we start taking notes and give it the support it deserves – good food, proper rest, exercise, and smart habits.
Hats off to the heroes inside us.”

Stay updated with Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal